Company news

BCAL Diagnostics Limited news in 2026

BCAL Diagnostics Limited's news releases, calls and decks from 2026, newest first.

View company

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

October 29, 2026

GSS: Response to Media Speculation & BCAL letter to GSS

October 16, 2026

BREASTESTplus 2 clinically validated

September 29, 2026

BCAL Introduces Avantect Multi-Cancer Early Detection Test

September 22, 2026

Appendix 4E and Annual Report to shareholders

August 28, 2026

BCAL Takes Interest in Genetic Signatures to 18.46%

August 25, 2026

BCAL Secures Funding for FY2027 Update

August 21, 2026

BCAL to Acquire Shares in Genetic Signatures

July 1, 2026

BCAL Secures Funding for FY2027

June 28, 2026

BCAL Develops New Blood Test for Breast Cancer Recurrence

June 17, 2026

BCAL Launches Early Detection Cancer Platform

May 19, 2026

BCAL Appoints Anne-Louise Arnett as Chief Executive Officer

May 10, 2026

BCAL Accelerates Rollout of Avantect Early Detection Tests

March 25, 2026

Half Yearly Report and Accounts

February 17, 2026

Shareholder Update

February 4, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 20, 2026

Decks in 2026